Merck & Co. will continue a huge patient study of an experimental cholesterol medicine – the last one standing in a once-promising new drug class – after an independent monitoring committee recommended the study continue.
Are you up for a challenge?
Merck & Co. will continue a huge patient study of an experimental cholesterol medicine – the last one standing in a once-promising new drug class – after an independent monitoring committee recommended the study continue.